As I recall Relenza was never approved in China because according to the BTA law suit GSK pulled the registration and stopped trials after they decided to stop supporting Relenza worldwide in 2000. Doubt that we will see Relenza sold any time soon in China.
- Forums
- ASX - By Stock
- peramivir failed in a clinical trial
As I recall Relenza was never approved in China because...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online